Akanocure Pharmaceuticals
West Lafayette, US · Founded 2014 · 1 known investors
Akanocure is a drug development company using a proprietary chemistry platform to create novel small-molecule therapies, with a focus on orphan and unmet needs in oncology and blocking metastatic processes. Its work spans chemical methodology development and classic drug discovery for cancer treatments.
Founders & leadership
Akanocure Pharmaceuticals was founded in 2014 by Philip L. Fuchs, Mohammad N. Noshi, and Sherine M. Abdelmawla.
PL
Philip L. FuchsCo-founder
MN
Mohammad N. NoshiCo-founder
SM
Sherine M. AbdelmawlaCo-founder
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1MofferedMar 2015 · Pharmaceuticals
▶$1MofferedMar 2015 · Pharmaceuticals
Officers, directors & promoters on the filing
- Philip L. FuchsExecutive Officer, Director
- Mohammad N. NoshiExecutive Officer, Director
- Sherine M. AbdelmawlaExecutive Officer, Director
- Offering amount
- $1M
- Minimum investment
- $25K
- Incorporated
- Limited Liability Company, Indiana, 2014
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 8
by search overlap
Onkure Therapeutics Inc13 shared keywordsOnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies. Its focus is on selective, allosteric small-molecule oncology therapeutics.
NovoCure10 shared keywordsNovocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.
NextCure10 shared keywordsNextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Flavocure Biotech5 shared keywordsFlavocure Biotech is a biotechnology company developing flavonoid-derived compounds from cannabis as therapeutics for cancers such as metastatic pancreatic cancer and other conditions. It conducts preclinical drug research and development.
Uniqure5 shared keywordsuniQure is a biotech company developing gene therapies for serious genetic diseases. The company's pipeline includes investigational treatments for conditions such as Huntington's disease, epilepsy, and Fabry disease.
Kura Oncology5 shared keywordsKura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.
LeadIQ5 shared keywordsLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.
Companies competing with Akanocure Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2021 | $256K |
| National Science Foundation | Phase II | 2020 | $950K |
| National Science Foundation | Phase I | 2018 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Akanocure Pharmaceuticals do?
- Akanocure is a drug development company using a proprietary chemistry platform to create novel small-molecule therapies, with a focus on orphan and unmet needs in oncology and blocking metastatic processes. Its work spans chemical methodology development and classic drug discovery for cancer treatments.
- Who founded Akanocure Pharmaceuticals?
- Akanocure Pharmaceuticals was founded by Philip L. Fuchs, Mohammad N. Noshi, Sherine M. Abdelmawla in 2014.
- Who are Akanocure Pharmaceuticals's investors?
- Akanocure Pharmaceuticals's investors include Elevate Ventures.
- Where is Akanocure Pharmaceuticals headquartered?
- Akanocure Pharmaceuticals is headquartered in West Lafayette, US.